We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+1.89%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$113B
AUM Growth
+$5.56B
Cap. Flow
+$4.14B
Cap. Flow %
3.68%
Top 10 Hldgs %
14.26%
Holding
11,559
New
1,144
Increased
4,238
Reduced
4,557
Closed
1,117

Sector Composition

Rank Sector Weight
1 Energy 8.95%
2 Financials 7.03%
3 Technology 6.55%
4 Healthcare 6.54%
5 Industrials 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCY
10026
DELISTED
ONCOLYTICS BIOTECH INC
ONCY
$2K ﹤0.01%
1,055
-16,550
-94% -$27.9K
LMNS
10027
DELISTED
LUMENIS LTD CL B ORD SHS (ISR)
LMNS
$2K ﹤0.01%
+161
New +$1.92K
TIGR
10028
DELISTED
TIGERLOGIC CORPORATION COM STK (DE)
TIGR
$2K ﹤0.01%
1,207
-427
-26% -$703
AMCF
10029
DELISTED
ANDATEE CHINA MARINE FUEL SVCS CORP COM STK (DE)
AMCF
$2K ﹤0.01%
+896
New +$1.58K
DRGS
10030
DELISTED
RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS
DRGS
$2K ﹤0.01%
41
-207
-83% -$9.33K
RGRP
10031
DELISTED
RBS PLC ROGERS ENHANCED PRECIOUS EXCHANGE METALS ETNS (UK)
RGRP
$2K ﹤0.01%
+117
New +$2.24K
CSMB
10032
DELISTED
CREDIT SUISSE X-LINKS 2XLEVERGED MERGER ARBITRAGE ETNS
CSMB
$2K ﹤0.01%
+100
New +$2.05K
ZEP
10033
PUT
DELISTED
ZEP INC COM STK (DE)
ZEP
$2K ﹤0.01%
100
-1,900
-95% -$32.7K
HPTX
10034
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$2K ﹤0.01%
69
-448
-87% -$12.1K
ENTR
10035
CALL
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
$2K ﹤0.01%
500
-400
-44% -$1.73K
LAS
10036
DELISTED
LENTUO INTL INC ADS REPSTG 2 ORD SHS (CYM)
LAS
$2K ﹤0.01%
592
-22
-4% -$82
AVIV
10037
CALL
DELISTED
AVIV REIT INC COM STK (MD)
AVIV
$2K ﹤0.01%
100
WHX
10038
DELISTED
WHITING USA TRUST I UNITS OF BENE INT
WHX
$2K ﹤0.01%
650
-6,144
-90% -$33.4K
AMCO
10039
DELISTED
ARMCO METALS HOLDINGS INC COM STK NEW (NV)
AMCO
$2K ﹤0.01%
400
PSTR
10040
DELISTED
POSTROCK ENERGY CORP COM STK (DE) NEW
PSTR
$2K ﹤0.01%
+167
New +$2.15K
PSMI
10041
PUT
DELISTED
PEREGRINE SEMICONDUCTOR CORP COM STK (DE)
PSMI
$2K ﹤0.01%
400
-2,600
-87% -$17K
TAM
10042
DELISTED
TAMINCO CORP COM
TAM
$2K ﹤0.01%
100
-5,780
-98% -$123K
FRF
10043
DELISTED
FORTEGRA FINL CORP COM STK (DE)
FRF
$2K ﹤0.01%
260
GAGA
10044
DELISTED
LE GAGA HOLDINGS LTD ADS
GAGA
$2K ﹤0.01%
782
-643
-45% -$2.17K
CHRM
10045
DELISTED
CHARM COMMUNICATIONS INC ADR REP STG SHS CL A (CYM)
CHRM
$2K ﹤0.01%
+373
New +$1.56K
GASX
10046
PUT
DELISTED
DIREXION DAILY NATURAL GAS RELATED BEAR 3X SHARES
GASX
$2K ﹤0.01%
+100
New +$2.4K
ZIPR
10047
DELISTED
ZIP REALTY, INC
ZIPR
$2K ﹤0.01%
500
-2,252
-82% -$10.2K
AH
10048
CALL
DELISTED
Accretive Health
AH
$2K ﹤0.01%
200
-200
-50% -$1.77K
SOQ
10049
DELISTED
SONDE RESOURCES CORP COM NEW (CAD)
SOQ
$2K ﹤0.01%
4,987
-21,831
-81% -$10.8K
CHYR
10050
DELISTED
CHYRONHEGO CORP COM STK (NY)
CHYR
$2K ﹤0.01%
+889
New +$2.39K

Similar funds

UBS's Q1 2014 Portfolio in Review

As of Q1 2014, UBS held 11,559 positions worth $113B, up 5.2% from $107B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS deployed $4.14B of net new capital in Q1 2014, opening 1,144 new positions and adding to 4,238 existing holdings. Its largest new stake was iShares MSCI USA Quality Factor ETF: 336,642 shares worth $19M.

By sector, the portfolio is most concentrated in Energy at 9% of assets, up from 8.5% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Herc Holdings, an estimated $419M trimmed.

  • UBS's largest Q1 2014 buy was iShares MSCI USA Quality Factor ETF: 336,642 shares worth $19M.
  • UBS added most to State Street SPDR S&P 500 ETF Trust in Q1 2014, an estimated $1.61B increase.
  • UBS's biggest Q1 2014 reduction was Herc Holdings, cutting an estimated $419M.
  • UBS fully exited COLE REAL ESTATE INVESTMENTS, INC COM in Q1 2014, selling an estimated $233M.
  • UBS's ten largest holdings make up 14% of its $113B portfolio in Q1 2014.
  • UBS opened 1,144 new positions and closed 1,117 in Q1 2014.
  • UBS's portfolio value rose 5.2% quarter-over-quarter to $113B.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.